Novotech

The current scenario in Pharmaceutical Packaging Development

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Alcami Strengthens Tennessee Facility with Quality, Packaging and Storage Capacity

Alcami Corporation has announced a series of strategic investments...

Aptar Advances Pharmaceutical Packaging as N-Sorb Technology Gains Patent Approval

Aptar Active Material Science, a division of AptarGroup, Inc.,...
- Advertisement -

Ultra high barrier films protect any dosage content

The Pharmaceutical Industry has always mainly focused on novel drug research, formulation development,ย  andย  subsequentย  clinicalย  trials.ย  Asย  withย  allย  otherย  phasesย  itย  presentsย  itsย  ownย  challenges. There is no use if packaging does not maintain the drug activity until it reaches the patient. Currently the role of packaging had expanded beyond protection and maintenance of product integrity. It has to also comply with major regulatory authorities such as Code of Federal Regulations ( CFR ) , us Guidance for Industry , Container Closure Systems, and EMA Guidance : Plastic immediate packaging materials.Inย  theย  lastย  twoย  decadesย  thereย  isย  anย  increasingย  demandย  forย  packaging solutions that improve product shelf life while maintaining product integrity during distribution.

The emerging trend of Ultra-Highโ€“Barrier Films
The demand for highly protective packaging solutions has fueled the development and manufacturing of Ultra- High- Barrier packaging films. While meeting all regulatory needs with although higher costs they off-set in the long term reduction in hidden costs. There are currently multiple options of ultra-High โ€“ Barrier films and pharmaceutical packaging engineers often find it difficult to understand the specific application of each of these products. The packaging requirement of any pharmaceutical drug is mainly governed by the nature of the drug product and its type of formulation, target market and data available from the innovator.The present article presents to guide pharmaceutical packaging engineers in deciding when to use ultra- high- barrier-films , the best practices in working with Ultra- High- Barrier โ€“ Films to ensure a smooth packaging operation , and last but not the least , different methods for testing packaging integrity.

Mono โ€“ Aclar โ€“ A key player in Ultra- High โ€“ Barrier โ€“ Films
Mono- Aclar films manufactured by Honeywell, have been well know and trusted for over 40 years by the worldโ€™s largest pharmaceutical companies. Primarily Aclar is a polychlorotrifluoroethylene (PCTFE) flouropolymer. They are optically clear, biochemically inert, flex โ€“crack and chemical resistant,ย  un-polar,ย  non-ย  flammable,ย  freeย  ofย  plasticizersย  andย  stabilizers,ย  withย  goodย  formingย  and non- altering properties. Table 1 compares different properties of Aclar and those of PVC.

The transformation of Mono- Aclar to ACG Aclar Laminates
ACG has more than two decades of experience inย  pharmaceuticalย  packaging.ย  ACGย  hasย  beenย  cateringย  toย  diverseย  industriesย  inย  moreย  thanย  80ย  countries, including, pharmaceutical, health care, personalย  careย  andย  medicalย  deviceย  sectors.ย  Byย  lamenting mono-Aclar with different appropriate films, ACG has introduced various ultra high barriers,ย  namedย  ACGย  Aclarย  laminates,ย  whichย  meetย  specificย  barrierย  requirementsย  ofย  eachย  formulationย  andย  offerย  theย  highestย  protectionย  against environmental factors.

Since ACG Aclar laminates are inert, they offer the best options for packaging of highly reactive drugย  formulations.ย  Anotherย  advantageย  ofย  ACGย  Aclarย  laminatesย  isย  thatย  itsย  push-throughย  forceย  is equivalent to other ultra โ€“high โ€“barrier films approvedย  byย  theย  USย  andย  Europeanย  regulatoryย  authorities

Types of Laminates

  • PVC/ ACLAR
  • PVC/PE/ ACLAR
  • PVC/EVOH/ACLAR
  • APET/ACLAR
  • APET/ EVOH/ ACLAR

Depicts the ACG Aclar laminates most commonly used in packaging

Working with ACG Aclar Laminates

The barrier properties of ACG Aclar Laminates can alter during the actual thermoforming process. The recommendation below will give you the best results when working with ACG Aclar laminates.

โ€ข Thermoforming of ACG Aclar Laminates
Typical forming temperatures for ACG Aclar Laminates ranges from 110C to 140C and sealing temperature ranging from 160C to 190C. These forming and sealing temperatures depends on speed of machine, available change parts, size of cavity and film structure being used.
โ€ข Use a flat forming machine instead of a Rotary one
A high pressure ( 6-8 Bar ) is needed for the formation of ACG Aclar laminates since they are one of the most durable high barrier films with a high melt flow index.
โ€ข Use Plug Assists
The thermoforming process of ACG Aclar is further simplified with plug assists, which allow proper cavity formation with appropriate thickness.
โ€ข Use a dedicated mold instead of a universal mold.

When thermoforming change parts are taken into consideration, dedicated molds are highly recommended over universal ones. Figure 4 because of an array of advantages they provide.

  • Uniform thickness distribution
  • Reduced stress formation
  • Ensures controlled Forming
  • Consistent Flange Width
  • Avoid Non- Homogeneous cooling
  • Minimize risk of micro- channeling in the sealed area

Packaging Integrity Tests of ACG Aclar Laminates
For blsters form, it is imperative to check whether the packaging offers the required protection, and this can be determined only by packaging integrity tests.

โ€ขย  Leak Detection Test
Also referred to as โ€˜ Methylene Blue Test โ€˜ , this method uses a vacuum chamber partially filled with a mixture of water and Methylene blue dye. Theย  blistersย  areย  submergedย  inย  thisย  liquidย  andย  held steady for a specific period at a specific level of vacuum drawn on the chamber. After the chamber is vented to the atmospheric pressure, cavities /seal areas of the blisters are examined for any sign of the blue dye.Theย  majorย  drawbackย  ofย  thisย  testย  isย  thatย  itย  isย  aย  destructiveย  testย  becauseย  theย  samplesย  testedย  cannot be used for weight gain test , and therefore requires statistical sampling to ensure that an acceptable number of blisters are detected.

โ€ขย  High Intensity Light Test
This simple test examines cracks in the foil. It is conducted in a dark room where a flash light is shinned through one side of the sealed blister. If there is no light coming through the foil and plastic, it means there is no pin holes in the seal.

โ€ขย  Weight Gain Test
This is by far the most important test for a blister pack even though it is time consuming, taking approximately 40 days. It measures the moisture permeability of packages filled with desiccant irrespective of the dosage amount. The blisters are kept in a labeled package holder individually, and their initial weight is measured (day Zero). Thenย  theย  blistersย  areย  placedย  inย  aย  humidityย  chamber as per ICH conditions.ย  Samples are weighed everyday for the next ten days at least every other day. After 10 days reading frequency can be reduced to once a week.Theย ย  resultsย ย  areย ย  reportedย ย  asย ย  weightย ย  gainย ย  (WGdayX ) in g package and plotted on a graph. A linear data indicates favorable results whereas Non-linearity may indicate a problem with the samples, saturated desiccant tablets, or the data collection method.

Conclusion
Ultra-barrier-Films are gaining popularity in the pharmaceutical industry owing to their ability to provide ultimate protection to pharmaceuticals against environmental factors, thereby boosting their shelf life. Although different types of ultra-high- barrier films are available in the market, packaging engineers still face the problem of selecting the right kind for the intended product because of the pressing timelines. To select the right barrier film, packaging engineers should first isolate the impurities that form in the products andย  identifyย  theย  underlyingย  reasons,ย  suchย  asย  moisture, oxygen, and light. The type of barrier film then can be selected accordingly.ACG Aclar laminates is one of the well known ultra- high- barrier packaging materials and is available in various types to meet every barrier requirementย  ofย  pharmaceuticalย  products.ย  Byย  following the best practices , ACG Aclar laminates provides the optimum barrier performance.

Author: Mr. Pranav Hiraskar

Mr. Pranav Hiraskar holds a Master degree in advanced chemical engineering for University of Manchester, England. He works in the business development division of high barrier films in ACG Films & Foils and caters to India and SAARC region.

Company: ACG


In the world of packaging, ACG is indisputably a recognized player offering its services to several industries across the world. ACG takes pride in being an award-winning manufacturer of a range of highquality barrier packaging films for the pharmaceutical, medical-device, healthcare, and food packaging sectors. We understand the critical role of packaging in pharma industry and consistently strive to provide reliable and innovative solutions to our customers building a symbiotic relationship of needs and offerings. ACGโ€™s diverse portfolio of packaging solutions includes pharmaceutical grade & camera-inspected range of aluminium-based foils, specialty packaging films, high-barrier, anticounterfeiting and polymer films. ACG offers pharmaceutical grade barrier packaging films that are manufactured right from PVC resin stage to calendering and slitting stage, which not only guarantees consistent quality but also ensures traceability of every batch supplied. Our world-class manufact... Read more »

Send Enquiry for this story

By submitting this form you agree to allow www.worldpharmatoday.com to contact you regarding your enquiry.
See our Privacy Policy to learn more.

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป